TScan Therapeutics to Present Discovery of T Cell Targets for COVID-19 at the Cell-Mediated Therapies for Infectious Disease Summit

TScan Therapeutics, Inc. Announces Pricing of Initial Public Offering

TScan Therapeutics Adds to Executive Leadership Team and Board of Directors

TScan Therapeutics Appoints Katina Dorton, J.D., M.B.A., to Its Board of Directors

TScan Therapeutics Strengthens Leadership Team with the Appointment of Brian M. Silver as Chief Financial Officer

TScan Therapeutics Announces $100 Million Series C Financing

TScan Therapeutics Appoints Brian M. Silver, J.D., to Its Board of Directors

TScan Therapeutics Announces Presentation at the 39th Annual J.P. Morgan Healthcare Conference

TScan Therapeutics Announces Partnership with QIAGEN to Develop T Cell-Based Laboratory Test for Comprehensive COVID-19 Immune Response

TScan Therapeutics Announces Presentations at Upcoming Conferences